The ROE as of September 2024 (TTM) for OKYO Pharma Limited (OKYO) is 0.37%

According to OKYO Pharma Limited’s latest financial reports and current stock price. The company's current ROE is 0.37%. This represents a change of -99.91% compared to the average of 399.61% of the last 4 quarters.

OKYO Pharma Limited (OKYO) Historical ROE (quarterly & annually)

How has OKYO ROE performed in the past?

The mean historical ROE of OKYO Pharma Limited over the last ten years is 28.98%. The current 0.37% ROE has changed -98.72% with respect to the historical average. Over the past ten years (40 quarters), OKYO's ROE was at its highest in in the September 2022 quarter at 1.60%. The ROE was at its lowest in in the March 2022 quarter at -97.66%.

OKYO Pharma Limited (OKYO) ROE by Quarter and Year

Discovering the peaks and valleys of OKYO Pharma Limited ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

OKYO Pharma Limited (OKYO) Average ROE

How has OKYO ROE performed in the past?

The current ROE of OKYO Pharma Limited (OKYO) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

OKYO Pharma Limited (OKYO) ROE vs. Peers

How is OKYO’s ROE compared to its peers?

OKYO Pharma Limited’s ROE is greater than Bionomics Limited (-150.24%), greater than Candel Therapeutics, Inc. (-629.29%), greater than Anebulo Pharmaceuticals, Inc. (-122.97%), less than Cingulate Inc. (11.47%), less than Unicycive Therapeutics, Inc. (0%), less than Quoin Pharmaceuticals, Ltd. (294.74%), greater than Cardio Diagnostics Holdings, Inc. (-112.11%), greater than Virax Biolabs Group Limited (-308.99%), greater than PaxMedica, Inc. Common Stock (-115.10%), greater than Senti Biosciences, Inc. (-1151.68%), greater than ZIVO Bioscience, Inc. (-91.09%), less than Cadrenal Therapeutics, Inc. Common Stock (673.84%), greater than Foghorn Therapeutics Inc. (-93.71%), less than Clearmind Medicine Inc. (140.34%), greater than Hillstream BioPharma, Inc. (-205.09%), greater than Coeptis Therapeutics, Inc. (-47249.59%), greater than Magenta Therapeutics, Inc. (-308.83%), greater than null (-61.71%),

Build a custom stock screener for OKYO Pharma Limited (OKYO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like OKYO Pharma Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

OKYO Pharma Limited (OKYO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like OKYO Pharma Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.